U.S. Markets closed

Juno Therapeutics jumps 53% after report Celgene is interested in buying the cancer drugmaker

Graham Rapier
Juno stock price

Markets Insider


NOW WATCH: The chief global strategist at Charles Schwab says a bitcoin crash won't infect the rest of the market

See Also:

SEE ALSO: A cancer treatment that's part of 'a big new field of medicine' just got approved